Harrington RA - Search Results

1

First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention.

Cohen MG, Purdy DA, Rossi JS, Grinfeld LR, Myles SK, Aberle LH, Greenbaum AB, Fry E, Chan MY, Tonkens RM, Zelenkofske S, Alexander JH, Harrington RA, Rusconi CP, Becker RC. Cohen MG, et al. Among authors: harrington ra. Circulation. 2010 Aug 10;122(6):614-22. doi: 10.1161/CIRCULATIONAHA.109.927756. Epub 2010 Jul 26. Circulation. 2010. PMID: 20660806 Clinical Trial.

2

Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I.

Becker RC, Corrao JM, Harrington R, Ball SP, Gore JM. Becker RC, et al. Am Heart J. 1991 Jan;121(1 Pt 1):220-44. doi: 10.1016/0002-8703(91)90986-r. Am Heart J. 1991. PMID: 1898680 Review. No abstract available.

3

Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part II.

Becker RC, Harrington R. Becker RC, et al. Am Heart J. 1991 Feb;121(2 Pt 1):627-40. doi: 10.1016/0002-8703(91)90746-5. Am Heart J. 1991. PMID: 1899318 Review.

4

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators.

Tcheng JE, Harrington RA, Kottke-Marchant K, Kleiman NS, Ellis SG, Kereiakes DJ, Mick MJ, Navetta FI, Smith JE, Worley SJ, et al. Tcheng JE, et al. Among authors: harrington ra. Circulation. 1995 Apr 15;91(8):2151-7. doi: 10.1161/01.cir.91.8.2151. Circulation. 1995. PMID: 7697843 Clinical Trial.

5

Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.

Topol EJ, Fuster V, Harrington RA, Califf RM, Kleiman NS, Kereiakes DJ, Cohen M, Chapekis A, Gold HK, Tannenbaum MA, et al. Topol EJ, et al. Among authors: harrington ra. Circulation. 1994 Apr;89(4):1557-66. doi: 10.1161/01.cir.89.4.1557. Circulation. 1994. PMID: 8149521 Clinical Trial.

6

Relation between activated clotting time during angioplasty and abrupt closure.

Narins CR, Hillegass WB Jr, Nelson CL, Tcheng JE, Harrington RA, Phillips HR, Stack RS, Califf RM. Narins CR, et al. Among authors: harrington ra. Circulation. 1996 Feb 15;93(4):667-71. doi: 10.1161/01.cir.93.4.667. Circulation. 1996. PMID: 8640994

7

Antiplatelet and antithrombin therapies in the acute coronary syndromes.

Alexander JH, Harrington RA. Alexander JH, et al. Among authors: harrington ra. Curr Opin Cardiol. 1997 Jul;12(4):427-37. Curr Opin Cardiol. 1997. PMID: 9263656 Review.

8

Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.

Alexander JH, Harrington RA. Alexander JH, et al. Among authors: harrington ra. Drugs. 1998 Dec;56(6):965-76. doi: 10.2165/00003495-199856060-00002. Drugs. 1998. PMID: 9878986 Review.

9

Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.

Hudson MP, Greenbaum AB, Harrington RA, Ohman EM. Hudson MP, et al. Among authors: harrington ra. J Thromb Thrombolysis. 1999 Jun;7(3):241-5. doi: 10.1023/a:1008974909124. J Thromb Thrombolysis. 1999. PMID: 10373717 Review.

10

Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: applicability to the practice of medicine in the United States.

Cohen M, Ferguson JJ 3rd, Harrington RA. Cohen M, et al. Among authors: harrington ra. Clin Cardiol. 1999 Oct;22 Suppl 6(Suppl 6):VI2-12. doi: 10.1002/clc.4960221703. Clin Cardiol. 1999. PMID: 10526702 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters